Biotechnology
Company Overview of Dermira Inc.
Company Overview
Dermira Inc., a development-stage biotech company, focuses on developing and commercializing therapies in dermatology. The company’s portfolio of dermatology therapeutics includes lemuteporfin, a potent and selective topical photodynamic therapy for sebaceous gland disorders, including acne; DRM01, a topical sebum inhibitor targeting acne and sebaceous gland hyperactivity; and DRM02, a topical kinase inhibitor targeting inflammatory skin diseases. The company was founded in 2010 and is based in Redwood City, California. It has operations in Vancouver, Canada.
2055 Woodside Road
Redwood City, CA 94061
United States
Founded in 2010
Key Executives for Dermira Inc.
Similar Private Companies By Industry
| Company Name | Region |
| Algorithme Pharma USA Inc. | United States |
| Matrivax Research & Development Corp. | United States |
| Phyton Biotech, Inc. | United States |
| BioSurface Technologies Corporation | United States |
| Collaborative Neuroscience Network, Inc. | United States |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| NYC2012, Inc. | United States |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| Rush University | United States |
| Greater Houston Partnership | United States |
Post a JobJobs
- Boston, MA | PwCPosted: Aug 28
- Madison, WI | Madison Area Technical CollegePosted: May 23
- Kennebunk, ME | CorningPosted: May 24
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
Sponsored Financial Commentaries
Sponsored Links
To contact Dermira Inc., please visit www.dermira.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
